Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Health News Nevada.
Press releases published on September 2, 2025
Lyell Immunopharma Announces Participation in September Investor Conferences
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing next-generation CAR T-cell therapies for patients with cancer, …
Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 27th Annual Global Investment Conference. The …
Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO
GlobeNewswire
·
September 2, 2025
MENLO PARK, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company) an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform …
Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Picard Medical, Inc. Announces Closing of $17 Million Initial Public Offering
GlobeNewswire
·
September 2, 2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that it closed its initial public offering of 4,250,000 shares of common stock, par value $0.0001 per share (the “ …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 2, 2025
CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted two newly-hired employees options to purchase an …
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 2, 2025
ORLANDO, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees an …
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference
GlobeNewswire
·
September 2, 2025
WESTLAKE VILLAGE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief Financial …
HealthEquity Reports Second Quarter Ended July 31, 2025 Financial Results
GlobeNewswire
·
September 2, 2025
Highlights of the second quarter include: Revenue of $325.8 million, an increase of 9% compared to $299.9 million in Q2 FY25. Net income of $59.9 million, an increase of 67% compared to $35.8 million in Q2 FY25, with non-GAAP net income of $94.6 million, …
Ascendis to Share Latest Endocrinology Rare Disease Data in 3 Oral Presentations at ASBMR 2025
GlobeNewswire
·
September 2, 2025
COPENHAGEN, Denmark, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced three oral presentations of its latest achondroplasia and hypoparathyroidism data at ASBMR 2025, the annual meeting of the American Society for Bone …
Mineralys Therapeutics Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
September 2, 2025
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), …
Cognition Therapeutics Closes $30 Million Registered Direct Offering to Two New Fundamental Institutional Investors, Including a Preeminent Global Investment Firm to Support Phase 3 Development of Zervimesine (CT1812)
GlobeNewswire
·
September 2, 2025
PURCHASE, N.Y., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, closed its previously announced registered …
Harms from Modified mRNA COVID-19 Vaccines Discussed in the Journal of American Physicians and Surgeons
GlobeNewswire
·
September 2, 2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Experience to date indicates that modified mRNA COVID-19 vaccines can disrupt every body system, and that urgent scrutiny and accountability are needed, write Andrew Zywiec, M.D., and others in the fall …
The Implications of Artificial Intelligence (AI) for Medicine Discussed in the Journal of American Physicians and Surgeons
GlobeNewswire
·
September 2, 2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Artificial intelligence (AI) is envisioned by many to be the future of medicine, and it is critical to understand its implications and the background of technocracy, which AI will serve, writes Patrick Wood …
Medidata Secures a Leader Position in Everest Group’s PEAK Matrix® Assessment for eCOA, Driving the New Patient Experience Forward
GlobeNewswire
·
September 2, 2025
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has been recognized as a Leader in Everest Group‘s Life Sciences Electronic Clinical Outcome …
Evidence for ‘Chemtrails’ Examined in the Journal of American Physicians and Surgeons
GlobeNewswire
·
September 2, 2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- The “chemtrails” theory gained prominence in the Make America Healthy Again (MAHA) movement, leading to the enactment of related legislative measures. In the fall issue of the Journal of American Physicians …
Expert on Sham Peer Review Discusses Tactic of Not Allowing Doctor’s Attorney to Speak, in the Journal of American Physicians and Surgeons
GlobeNewswire
·
September 2, 2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- A physician who is a victim of sham peer review at his hospital may be shocked to learn that some medical staff bylaws prohibit the physician’s attorney from speaking at the peer review hearing, writes …
President of the Association of American Physicians and Surgeons (AAPS) Urges Doctors to ‘Think outside the Box’
GlobeNewswire
·
September 2, 2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- In these days of protocols and “evidence-based medicine,” skills of independent thinking and judgment are being lost to “cookbook medicine,” writes Erika L. LeBaron, D.O., M.S.N., in the fall issue of the …
Honoring a Legacy of Compassion: The Dr. Le Thu Medical Scholarship Empowers Future Healers
GlobeNewswire
·
September 2, 2025
BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Dr. Le Thu Medical Scholarship is now open for applications, offering a transformative opportunity for aspiring medical students across the United States. Established in honor of Dr. Le Thu—a globally …